Tresiba® demonstrated significantly improved blood sugar control and lower rates of hypoglycemia versus insulin Toujeo® in real-world evidence studys... Read More

Major Partnership set to tackle Diabetes; One of Alberta’s most significant health concerns... Read More

Real-world data show significant weight loss in people receiving Saxenda®... Read More

Global News

Press releases from the Denmark headquarters.


Visit the pressroom of the website for our headquarters in Denmark where you can access the latest corporate stock exchange announcements, an image library, interim and annual reports and other relevant communication from Novo Nordisk A/S.


Media Contacts

For all media related inquiries, please contact the Corporate Communications team at Novo Nordisk Canada Inc.

Tel: 905-629-6612
Email: Kate Hanna -

For out of office hours, please contact Novo Nordisk, Global Media Relations
Tel: +45 4444 8888

If you have concerns regarding any Novo Nordisk product, please call customer care at 1-800-465-4334
or email